Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2025-12-24 @ 4:20 PM
NCT ID:
NCT00896766
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of B-cell precursor acute lymphoblastic leukemia (ALL)
* High-risk disease
* Participation in clinical trial COG-P9906 required (pilot project)
* In complete remission
* Consented to future studies using banked tissue specimens
* Participation in clinical trial and COG-AALL03B1 and linked therapeutic studies COG-AALL0232 and COG- AALL0331(expansion project)
* Experienced a bone marrow relapse within 36 months of initial diagnosis
* Consented to future studies using banked tissue specimens
* Have matched ALL blast and germline specimens
* Demographic, clinical and pathologic data elements for these biospecimens available
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
21 Years
Study:
NCT00896766
Study Brief:
Protocol Section:
NCT00896766